Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway-Reference-Cited by-同舟云学术

Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway

Published:2020-03-25 Issue:7 Volume:12 Page:5640-5650
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Zhang Ye¹,Liu Xinxin²,Zhang Junying³,Xu Yuanyuan¹,Shao Jie¹,Hu Yue¹,Shu Peng¹,Cheng Haibo¹⁴

Affiliation:

1. Department of Oncology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu Province, China

2. Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu Province, China

3. Clinical Cancer Research Center, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, Jiangsu Province, China

4. The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu Province, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic and therapeutic perspectives of miRNA-PTEN signaling axis in cancer therapy resistance;Biochemical Pharmacology;2024-08

2. Exosomal miR-19a derived from melanoma cell promotes the vemurafenib resistance of malignant melanoma through directly targeting LRIG1 to reactivate AKT and MAPK pathway;Pathology - Research and Practice;2024-08

3. Synthesis and Regulation of miRNA, Its Role in Oncogenesis, and Its Association with Colorectal Cancer Progression, Diagnosis, and Prognosis;Diagnostics;2024-07-07

4. SNHG4-mediated PTEN destabilization confers oxaliplatin resistance in colorectal cancer cells by inhibiting ferroptosis;Apoptosis;2024-04-04

5. Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer;Translational Oncology;2024-02